The global Anticoagulant Market Growth Accelerated by Increasing Incidence of Cardiovascular Diseases
Anticoagulants are widely used medications that help prevent blood clots from forming or growing larger in the body. They work by interfering with the blood coagulation system, which is responsible for blood clotting. Some common examples of anticoagulants include warfarin, apixaban, rivaroxaban, and heparin. They are commonly prescribed to patients with conditions such as atrial fibrillation, deep vein thrombosis, pulmonary embolism, and mechanical heart valves. The growing prevalence of cardiovascular diseases and rising geriatric population has significantly driven the demand for anticoagulants over the past few years. The global Anticoagulant Market is estimated to be valued at US$ 36830.47 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The increasing incidence of cardiovascular diseases is one of the major trends fueling the growth of the anti...